Table 1.
Clinical information of the EPS fluids analyzed by MudPIT proteomics
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | |
|---|---|---|---|---|---|---|---|---|---|
| Age | 64 | 53 | 67 | 65 | 70 | 50 | 61 | 69 | 59 |
| PSAa | 37.5 | 6.7 | 7.3 | 4.8 | 5.1 | 4.1 | 3.5 | 8.7 | 6.2 |
| Stage | T2b | T1c | T1c | T1c | T1c | T1c | T1c | T1c | T1c |
| Gleasonb | 4+3 | 3+4 | 3+4 | 3+3 | 3+4 | 3+3 | 3+4 | 3+4 | 3+3 |
|
Percent Tumorc |
75 | 25 | 2 | 2 | 5 | 5 | 20 | 40 | 1 |
|
Prostate Volumed |
53 | 41 | 56 | 31 | 96 | 48 | 70 | 42 | 73 |
a
Serum PSA values, ng/ml
b
Gleason score determined by pathology post-prostatectomy
c
Determined by post-prostatectomy pathology
d
Determine pre-prostatectomy by transurethral ultrasound measurements